Free Trial

JPMorgan Chase, KBR rise; Global Payments, Exxon Mobil fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

ON Semiconductor Corp., up $6.37 to $78.33.

The semiconductor components maker reported strong first-quarter financial results.

Norwegian Cruise Line Holdings Inc., up $1.19 to $14.54.

The cruise operator raised its profit forecast for the year.

JPMorgan Chase & Co., up $2.96 to $141.20.

The bank bought all of First Republic Bank's deposits and most of its assets after regulators seized the troubled bank.

Iveric Bio Inc., up $5.16 to $38.05.

Astellas Pharma is buying the biopharmaceutical company for about $5.9 billion.

KBR Inc., up $2.43 to $59.16.

The engineering and construction company reported strong first-quarter profit and revenue.

Park Hotels & Resorts Inc., up 25 cents to $12.30.

The real estate investment trust beat Wall Street's first-quarter financial forecasts.

Global Payments Inc., down $9.71 to $103.

CEO Jeffrey S. Sloan is stepping down from the electronics payment processing company.

Exxon Mobil Corp.. down $3.67 to $114.67.

Crude oil prices fell, weighing down energy stocks.

Should You Invest $1,000 in KBR Right Now?

Before you consider KBR, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KBR wasn't on the list.

While KBR currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines